Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: Incidence and outcomes

Circulation

Volumn 98, Issue 23, 1998, Pages 2567-2573

  Newby, Keith H ^a   Thompson, Trevor ^a   Stebbins, Amanda ^a   Topol, Eric J ^a   Califf, Robert M ^a   Natale, Andrea ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Arrhythmia; Myocardial infarction; Thrombolysis

Indexed keywords

HEPARIN; STREPTOKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; FEMALE; FIBRINOLYTIC THERAPY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0032497903     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.23.2567     Document Type: Article

References (26)

1. Nicod P, Gilpin E, Dittrich H, Wright M, Engler R, Rittlemeyer J, Henning H, Ross J. Late clinical outcome in patients with early ventricular fibrillation after myocardial infarction. J Am Coll Cardiol. 1988;11:464-470.
2. Tofler GH, Stone PH, Muller JE, Rutherford JD, Willich SN, Gustafson NF, Poole WE, Sobel BE, Willerson JT, Robertson T, Passamani E, Braunwald E, and the MILIS Study Group. Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS study). Am J Cardiol. 1987;60:755-761.
3. Behar S, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Principal Investigators of the SPRINT study. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Am J Cardiol. 1990;66: 1208-1211.
4. Gruppo Italiano Per Lo Studio della Streptochinasi NeH'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.
5. ISIS-I (First International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2:57-66.
6. Lawrie DM, Higgins MR, Godman MJ, Oliver MF, Julian DG, Donald KW. Ventricular fibrillation complicating acute myocardial infarction. Lancet. 1968;1:523-528.
7. Lawrie DM. Long-term survival after ventricular fibrillation complicating acute myocardial infarction. Lancet. 1969;2:1085-1087.
8. Goldberg R, Szklo M, Tonascia JA, Kennedy HL. Acute myocardial infarction: prognosis complicated by ventricular fibrillation or cardiac arrest. JAMA. 1979;241:2024-2027.
9. Conley MJ, McNeer JF, Lee KL, Wagner GS, Rosati RA. Cardiac arrest complicating acute myocardial infarction: predictability and prognosis. Am J Cardiol. 1977;39:7-12.
10. Volpi A, Cavalli A, Franzosi MG, Maggioni A, Mauri F, Santoro E, Tognoni G, GISSI investigators. One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol. 1989;63:1174-1178.
11. Volpi A, Maggioni A, Franzosi MG, Pampallona S, Mauri F, Tognoni G. In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med. 1987;317: 257-261.
12. Eldar M, Sievner Z, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S, SPRINT study group. Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. Ann Intern Med. 1992;117:31-36.
13. Berger PB, Ruocco NA, Ryan TJ, Frederick MM, Podrid PJ. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. J Am Coll Cardiol. 1993;22:1773-1779.
14. Volpi A, Cavalli A, Santoro E, Tognoni G, GISSI Investigators. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction: evidence for a protective effect of thrombolytic therapy. Circulation. 1990;82:1279-1288.
15. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, Tavazzi L, Tognoni G, on behalf of GISSI-2 Investigators. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation. 1993;87:312-322.
16. Battle WE, Naimi S, Avitall B, Brilla AH, Banas JS, Bete JM, Levine HJ. Distinctive time course of ventricular vulnerability to fibrillation during and after release of coronary ligation. Am J Cardiol. 1974;34:42-47.
17. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL, for the TEAM-3 Investigators. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction: ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 study. Circulation. 1993;87:1829-1839.
18. Richards DAB, Byth K, Ross DL, Uther JB. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation. 1991;83:756-763.
19. Heidbuchel H, Tack J, Vanneste L, Ballet A, Ector H, Van de Werf F. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a β-blocker or a bradycardiac agent on their incidence. Circulation. 1994; 89:1051-1059.
20. Brugada P, Wellens F, Andries E. A prophylactic implantable cardioverter-defibrillator? Am J Cardiol. 1996;78(suppl 5A):128-133.
21. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
22. Ryden L, Ariniego R, Arnman K, Herlitz J, Hjalmarson A, Holmberg S, Reyes C, Smedgard P, Svedberg K, Vedin A, Waagstein F, Waldenstrom A, Wilhelmsson C, Wedel H, Yamamoto M. A double-blind trial of metoprolol in acute myocardial infarction: effects on ventricular tachyarrhythmias. N Engl J Med. 1983;308:614-618.
23. Norris RM, Brown MA, Clarke ED, Barnaby PF, Geary GG, Logan RL, Sharpe DN. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet. 1984;2:883-886.
24. Sogaard P, Gotzsche CO, Ravkilde J, Norgaard A, Thygesen K. Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction: effect of intervention with captopril. Circulation. 1994;90:101-107.
25. Budaj A, Cybulski J, Karczmarewicz S, Maciejewicz J, Wisniewski M, Ceremuzynski L. Effects of captopril on ventricular arrhythmia in the early and late phase of suspected acute myocardial infarction. Eur Heart J. 1996;17:1506-1510.
26. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.